E Fund Management Co., Ltd. - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 157 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
E Fund Management Co., Ltd. ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2023$175
-14.6%
12,429
-6.5%
0.01%
-6.7%
Q1 2023$205
-5.5%
13,288
+0.4%
0.02%
-16.7%
Q4 2022$217
-99.9%
13,239
-4.7%
0.02%
-25.0%
Q3 2022$257,000
+8.9%
13,887
-22.6%
0.02%
+14.3%
Q2 2022$236,000
+20.4%
17,953
-15.3%
0.02%
+250.0%
Q1 2022$196,000
+12.0%
21,190
+18.2%
0.01%0.0%
Q4 2021$175,00017,9330.01%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$15,385,74319.76%
Redmile Group, LLC 4,475,384$56,926,8842.71%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,897,606$87,737,5481.93%
Parkman Healthcare Partners LLC 597,403$7,598,9661.39%
Ghost Tree Capital, LLC 325,000$4,134,0001.36%
BRAIDWELL LP 3,336,221$42,436,7311.34%
AlphaCentric Advisors LLC 132,000$1,679,0400.95%
ARMISTICE CAPITAL, LLC 4,612,000$58,664,6400.90%
Sunesis Advisors, LLC 96,299$1,224,9230.87%
EcoR1 Capital, LLC 993,000$12,630,9600.43%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders